EverSource Wealth Advisors’s Anbio Biotechnology NNNN Stock Holding History

EverSource Wealth Advisors’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.56K	Sell	187 -79	-30%	-$1.98K	﹤0.01%	3621
2026 Q1	$6.83K	Buy	+266	New	+$6.94K	﹤0.01%	3111

Other funds holding NNNN

BFS

Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

EverSource Wealth Advisors's NNNN Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Anbio Biotechnology (NNNN) stake by 30% in Q2 2026, selling an estimated $1.98K and leaving 187 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #3621.

EverSource Wealth Advisors first reported a position in NNNN in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.83K in Q1 2026. 2 funds tracked by Wall St. Rank hold NNNN as of Q2 2026.

EverSource Wealth Advisors held 187 shares of Anbio Biotechnology worth $2.56K as of Q2 2026.
EverSource Wealth Advisors sold 79 Anbio Biotechnology shares in Q2 2026, an estimated $1.98K.
Anbio Biotechnology made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3621 holding.
EverSource Wealth Advisors first reported a position in Anbio Biotechnology in Q1 2026 and has held it in 2 quarters since.
EverSource Wealth Advisors's Anbio Biotechnology position peaked at $6.83K in Q1 2026.
2 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.